Plus   Neg

TUI Slips To Hefty Loss In FY20; Expects To Return To Profitable Growth From FY22 Onwards

Tour operator TUI AG (TUIFF.PK) reported Thursday that its fiscal 2020 loss attributable to shareholders was 3.08 billion euros, compared to last year's profit of 532 million euros, hurt by coronavirus pandemic.

Underlying loss per share were 5.45 euros, compared to profit of 0.89 euro a year ago.

Reported EBIT was loss of 2.96 billion euros, compared to profit of 769 million euros last year. Underlying EBIT loss was 3.03 billion euros, compared to profit of 894 million euros last year.

Revenue declined 58 percent to 7.95 billion euros from 18.93 billion euros last year reflecting covid-19 travel restrictions during Summer 2020.

Full-year customer volume of 8.1 million was down 62% on prior year. Since restart of operations in mid-June, the company reported more than 2 million customer volume.

The dividend has been suspended as required by terms of German Support Packages, and the company said it still feels unable to announce specific guidance in light of the ongoing pandemic situation.

However, the company expects fiscal 2021 to be a year of transition and for the Group to return to profitable growth from FY22 onwards.

As a result of the increasing travel restrictions caused by the rising number of infections and the associated later booking behaviour of some customers, the company currently expects to operate an adjusted capacity of 20% for Winter 2020/21 which will be weighted towards financial Q2.

The company continues to expect to operate an adjusted capacity of 80% for Summer 2021, which will be flexed as it gains more visibility on future imposed travel restrictions.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Chico's FAS Inc. (CHS) Tuesday reported a wider year-over-year net loss for the fourth quarter. Meanwhile, Kohl's Corp.'s (KSS) fourth-quarter net income grew 29 percent from the previous year. But Abercrombie & Fitch Co.'s (ANF) fourth-quarter net income decreased 1 percent from the prior year. The U.S. Food and Drug Administration has approved the marketing of a new robotically-assisted surgical device (RASD) that can facilitate transvaginal hysterectomy in certain patients using minimally-invasive surgical instruments. The Hominis Surgical System of Memic Innovative Surgery Ltd., the U.S. subsidiary of Israeli biotechnology company memic Ltd., has been granted marketing authorization. Canadian cannabis company Canopy Growth Corp. (CGC, WEED.TO) announced Tuesday the launch of its Cannabidiol (CBD) beverage brand Quatreau in the high-potential U.S. market. Quatreau will be sold on Canopy's one-stop U.S. e-commerce destination, www.shopcanopy.com. Quatreau is a premium ready-to-drink...
Follow RTT